Business
NovaBay Pharmaceuticals receives unsolicited offer from Refresh Acquisitions
[ad_1]
Robert Daly
NovaBay Pharmaceuticals (NYSE:NBY) announced on Tuesday that it has received an unsolicited, non-binding offer from Refresh Acquisitions to purchase its Avenova brand, which it deems a “superior proposal” compared to its current asset purchase agreement with PRN Physician Recommended Nutriceuticals.
[ad_2]
